Geode Capital Management
NWBO

Geode Capital Management’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Geode Capital Management’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-255,495
Closed -$139K – 4128
2016
Q3 		$139K Buy
255,495
+276
+0.1% +$126 ﹤0.01% 3717
2016
Q2 		$148K Sell
255,219
-46,963
-16% -$50.1K ﹤0.01% 3686
2016
Q1 		$441 Buy
302,182
+3,846
+1% +$7.59K ﹤0.01% 3291
2015
Q4 		$954K Buy
298,336
+533
+0.2% +$2.56K ﹤0.01% 2932
2015
Q3 		$1.86M Sell
297,803
-9,980
-3% -$93.3K ﹤0.01% 2489
2015
Q2 		$3.06M Buy
307,783
+70,174
+30% +$615K ﹤0.01% 2238
2015
Q1 		$1.75M Buy
237,609
+10,778
+5% +$72.5K ﹤0.01% 2527
2014
Q4 		$1.21M Buy
226,831
+4,617
+2% +$23.6K ﹤0.01% 2726
2014
Q3 		$1.12M Buy
222,214
+2,121
+1% +$13K ﹤0.01% 2714
2014
Q2 		$1.48M Buy
220,093
+62,368
+40% +$397K ﹤0.01% 2568
2014
Q1 		$1.14M Buy
157,725
+61,532
+64% +$365K ﹤0.01% 2700
2013
Q4 		$362K Buy
96,193
+32,833
+52% +$127K ﹤0.01% 3216
2013
Q3 		$212K Buy
+63,360
New +$221K ﹤0.01% 3290

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
MBT
Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Geode Capital Management's NWBO Position: Q4 2016 in Review

Geode Capital Management sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 255,495 shares — an estimated $139K sold.

Geode Capital Management first reported a position in NWBO in Q3 2013 and held it in 13 quarters. The position peaked at $3.06M in Q2 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • Geode Capital Management reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
  • Geode Capital Management sold 255,495 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $139K.
  • Geode Capital Management first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q3 2013 and held it in 13 quarters.
  • Geode Capital Management's Northwest Biotherapeutics, Inc. Common stock position peaked at $3.06M in Q2 2015.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Geode Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.